Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2020-08-11 Capital/Financing Update
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT
Capital/Financing Update Classification · 99% confidence The document is a press release titled "EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE’S ANTIBIOTIC PROJECT". It announces a new partnership, in-licensing of a program, and receipt of funding from CARB-X. This type of announcement, detailing strategic business developments, partnerships, and non-financial operational milestones, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, DIV). It is a general corporate news item disseminated via DGAP (a service often used for regulatory announcements). Since it is not a specific financial report, a management discussion, or a director dealing report, the most appropriate fallback category for a general corporate announcement that is not a standard financial filing is Regulatory Filings (RNS), as RNS is defined as the fallback for miscellaneous filings that do not neatly fit elsewhere, especially when disseminated through official news services like DGAP.
2020-08-11 English
EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020
Report Publication Announcement Classification · 99% confidence The document is a press release dated August 5, 2020, announcing that EVOTEC SE will report its financial results for the 'first half-year of 2020' on August 12, 2020. It details the time and access information for the subsequent conference call to discuss these results. Since this document is an announcement *about* the upcoming release of periodic financial results (Half-Year Results) and includes details for the associated conference call, it functions as an Earnings Release (ER) or a precursor to the full Interim Report (IR). However, the primary focus is the announcement of the results release date and the conference call details, which aligns closely with the function of an Earnings Release (ER) which provides initial highlights or the schedule for results disclosure. Given the context of announcing the date for 'Half Year Results' and providing conference call details, it is best classified as an Earnings Release (ER) announcing the event, rather than the comprehensive Interim Report (IR) itself, which would follow on the 12th. It is not a full transcript (CT) or a full report (IR). It is an announcement of results.
2020-08-05 English
EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY
M&A Activity Classification · 99% confidence The document is a press release dated August 5, 2020, announcing a strategic partnership between Evotec SE and Secarna Pharmaceuticals regarding antisense therapy development. It uses keywords like "News Details," "DGAP-News," and discusses a new business agreement, not periodic financial results (like 10-K or ER), management changes (MANG), or shareholder voting (DVA). Since it is a general corporate announcement about a strategic development that doesn't fit into the more specific categories like M&A (TAR) or Financing (CAP), it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings) as per the provided definitions, or potentially a general corporate news item. Given the structure (DGAP News, dissemination notice), RNS is the most appropriate fit for a non-standard, material corporate announcement.
2020-08-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' by BlackRock, Inc. in Evotec SE, referencing specific German securities laws (WpHG Sections 33, 34, 38, 40). This content directly relates to changes in significant share ownership thresholds, which corresponds precisely to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory announcement disseminated via DGAP, the specific nature of the content (major holding change) overrides the general 'RNS' fallback.
2020-07-31 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Evotec SE: Release according to Article 41 of the WpHG' and explicitly announces the 'Publication of total number of voting rights' following a 'Conditional capital increase'. This type of announcement, detailing changes in the total number of voting rights, aligns directly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions a capital measure, the core purpose is reporting the resulting voting rights count, making DVA the most precise fit over CAP.
2020-07-31 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages (3.07% new total) held by a major shareholder (BlackRock, Inc.) in Evotec SE, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels crossing thresholds, which aligns best with the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, MRQ is the specific regulatory filing type for reporting these changes in holdings, whereas DVA is for the *results* of a vote.
2020-07-24 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.